Alnorin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlnorin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor agonists
TargetsTumor necrosis factor
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVector
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVector
Active IndicationsN/A
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A